Citations

Mayo Clinic

Clear

29 citation(s) found for "Waldman, Scott A".

Patient-Centric Clinical Pharmacology Advances the Path to Personalized Medicine
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Biomarkers in Medicine | November 21, 2011 | Volume: 5 | Issue: 6 | Pages: 697-700

10.2217/bmm.11.78 | PMID 22103605 Get It

MicroRNA Signatures as Diagnostic and Therapeutic Targets
Waldman, Scott A. , Terzic, André

Laboratory Medicine Online | January 20, 2011 | Volume: 1 | Issue: 1 | Pages: 1

10.3343/lmo.2011.1.1.1 Get It

Translational Medicine: Path to Personalized and Public Health
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Biomarkers in Medicine | December 6, 2010 | Volume: 4 | Issue: 6 | Pages: 787-790

10.2217/bmm.10.101 | PMID 21133696 Get It

Clinical Pharmacology: A Paradigm for Individualized Medicine
Waldman, Scott A. , Kraft, Walter K. , Nelson, Timothy J. , Terzic, André , Nelson, Timothy J , Waldman, Scott A

Biomarkers in Medicine | December 15, 2009 | Volume: 3 | Issue: 6 | Pages: 679-684

10.2217/bmm.09.76 | PMID 20477706 Get It

MicroRNA Signatures as Diagnostic and Therapeutic Targets
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Clinical Chemistry | May 28, 2008 | Volume: 54 | Issue: 6 | Pages: 943-944

10.1373/clinchem.2008.105353 | PMID 18509012 Get It

Therapeutic Burden in Cancer Revealed by Molecular Staging
Waldman, Scott A. , Terzic, André

Biomarkers in Medicine | January 29, 2008 | Volume: 2 | Issue: 1 | Pages: 1-3

10.2217/17520363.2.1.1 | PMID 20477357 Get It

Targeted Diagnostics and Therapeutics for Individualized Patient Management
Waldman, Scott A. , Terzic, André

Biomarkers in Medicine | May 25, 2007 | Volume: 1 | Issue: 1 | Pages: 3-8

10.2217/17520363.1.1.3 | PMID 20477454 Get It

Bacterial enterotoxins are associated with resistance to colon cancer
Pitari, Giovanni M. , Zingman, Leonid V. , Hodgson, Denice M., Алексеев, А. Э., Kazerounian, Shideh, Bienengraeber, Martin, Waldman, Scott A. , Hajnóczky, György , Terzic, André , Waldman, Scott A

Proceedings of the National Academy of Sciences | March 4, 2003 | Volume: 100 | Issue: 5 | Pages: 2695-2699

10.1073/pnas.0434905100 | PMID 12594332 Get It

One half million patients suffer from colorectal cancer in industrialized nations, yet this disease exhibits a low incidence in under-developed countries. This geographic imbalance suggests an environmental contribution to the resistance of endemic populations to intestinal neoplasia. A common epidemiological characteristic of these colon cancer-spared regions is the prevalence of enterotoxigenic bacteria associated with diarrheal disease. Here, a bacterial heat-stable enterotoxin was demonstrated to suppress colon cancer cell proliferation by a guanylyl cyclase C-mediated signaling cascade. The heat-stable enterotoxin suppressed proliferation by increasing intracellular cGMP, an effect mimicked by the cell-permeant analog 8-br-cGMP. The antiproliferative effects of the enterotoxin and 8-br-cGMP were reversed by L- cis -diltiazem, a cyclic nucleotide-gated channel inhibitor, as well as by removal of extracellular Ca 2+ , or chelation of intracellular Ca 2+ . In fact, both the enterotoxin and 8-br-cGMP induced an L- cis -diltiazem-sensitive conductance, promoting Ca 2+ influx and inhibition of DNA synthesis in colon cancer cells. Induction of this previously unrecognized antiproliferative signaling pathway by bacterial enterotoxin could contribute to the resistance of endemic populations to intestinal neoplasia, and offers a paradigm for targeted prevention and therapy of primary and metastatic colorectal cancer.
Regulation of Nitric Oxide-Responsive Recombinant Soluble Guanylyl Cyclase by Calcium
Parkinson, Scott J., Jovanović, Aleksandar , Jovanovic, Sofija, Wagner, Frank, Waldman, Scott A. , Jovanovic, Sofija, Terzic, André , Waldman, Scott A

Biochemistry | July 26, 2002 | Volume: 38 | Issue: 20 | Pages: 6441-6448

10.1021/bi990154v | PMID 10350462 Get It